264 related articles for article (PubMed ID: 21258408)
1. Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer.
Booy EP; Henson ES; Gibson SB
Oncogene; 2011 May; 30(20):2367-78. PubMed ID: 21258408
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis.
Goncharenko-Khaider N; Matte I; Lane D; Rancourt C; Piché A
Mol Cancer; 2012 Nov; 11():84. PubMed ID: 23158473
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Leu CM; Chang C; Hu C
Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1.
Wyrzykowska P; Stalińska K; Wawro M; Kochan J; Kasza A
Biochim Biophys Acta; 2010 Sep; 1799(9):616-21. PubMed ID: 20727996
[TBL] [Abstract][Full Text] [Related]
5. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells.
Groot M; Boxer LM; Thiel G
Eur J Cell Biol; 2000 Dec; 79(12):924-35. PubMed ID: 11152283
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
[TBL] [Abstract][Full Text] [Related]
10. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Ca
Duran P; Sandoval A; González-Ramírez R; Zarco N; Felix R
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E232-E244. PubMed ID: 32369417
[TBL] [Abstract][Full Text] [Related]
12. ETS-domain transcription factor Elk-1 mediates neuronal survival: SMN as a potential target.
Demir O; Aysit N; Onder Z; Turkel N; Ozturk G; Sharrocks AD; Kurnaz IA
Biochim Biophys Acta; 2011 Jun; 1812(6):652-62. PubMed ID: 21362474
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-mediated activation of the ETS domain transcription factor Elk-1 requires nuclear calcium.
Pusl T; Wu JJ; Zimmerman TL; Zhang L; Ehrlich BE; Berchtold MW; Hoek JB; Karpen SJ; Nathanson MH; Bennett AM
J Biol Chem; 2002 Jul; 277(30):27517-27. PubMed ID: 11971908
[TBL] [Abstract][Full Text] [Related]
14. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
[TBL] [Abstract][Full Text] [Related]
16. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
Day BW; Stringer BW; Spanevello MD; Charmsaz S; Jamieson PR; Ensbey KS; Carter JC; Cox JM; Ellis VJ; Brown CL; Walker DG; Inglis PL; Allan S; Reynolds BA; Lickliter JD; Boyd AW
Neuro Oncol; 2011 Nov; 13(11):1202-12. PubMed ID: 21846680
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway.
Henson ES; Gibson EM; Villanueva J; Bristow NA; Haney N; Gibson SB
J Cell Biochem; 2003 Aug; 89(6):1177-92. PubMed ID: 12898516
[TBL] [Abstract][Full Text] [Related]
18. Activation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells.
Bernal-Mizrachi E; Wen W; Srinivasan S; Klenk A; Cohen D; Permutt MA
Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1286-99. PubMed ID: 11701445
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
20. Transient and sustained ERK phosphorylation and nuclear translocation in growth control.
Adachi T; Kar S; Wang M; Carr BI
J Cell Physiol; 2002 Aug; 192(2):151-9. PubMed ID: 12115721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
